The predicted probability of prostate cancer in all patients (Supplementary Figure 2A) and patients with PSA 4–10 ng/ml (Supplementary Figure 2B) increased with the value of PZ-ratio. The gene discussed is KLK3; the disease is prostate carcinoma.